Oloctinebart Biosimilar - Research Grade

Human

LGALS3

5mg/ml

Human IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH2932

P08699

Blue ice

Galectin-3 (LGALS3) is a beta-galactoside-binding lectin involved in fibrosis, inflammation, and tumour progression, and is a widely investigated target across multiple disease areas. This anti-human LGALS3 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of oloctinebart, provided for research use only. Manufactured to in vivo quality with a low-endotoxin profile, it is available in scalable milligram (mg) to gram (g) quantities for laboratories running bulk or high-throughput studies. It is well suited to galectin-binding assays, in vitro functional screening, fibrosis and inflammation models, and in vivo preclinical work as a consistent reagent.

Detects human LGALS3

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks